<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37226016</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1437-160X</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Rheumatology international</Title><ISOAbbreviation>Rheumatol Int</ISOAbbreviation></Journal><ArticleTitle>Systemic lupus erythematosus: latest insight into etiopathogenesis.</ArticleTitle><Pagination><StartPage>1381</StartPage><EndPage>1393</EndPage><MedlinePgn>1381-1393</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00296-023-05346-x</ELocationID><Abstract><AbstractText>Systemic lupus erythematosus (SLE) is a complex autoimmune disorder of unknown etiology. Multifactorial interaction among various susceptible factors such as environmental, hormonal, and genetic factors makes it more heterogeneous and complex. Genetic and epigenetic modifications have been realized to regulate the immunobiology of lupus through environmental modifications such as diet and nutrition. Although these interactions may vary from population to population, the understanding of these risk factors can enhance the perception of the mechanistic basis of lupus etiology. To recognize the recent advances in lupus, an electronic search was conducted among search engines such as Google Scholar and PubMed, where we found about 30.4% publications of total studies related to genetics and epigenetics, 33.5% publications related to immunobiology and 34% related to environmental factors. These outcomes suggested that management of diet and lifestyle have a direct relationship with the severity of lupus that influence via modulating the complex interaction among genetics and immunobiology. The present review emphasizes the knowledge about the multifactorial interactions between various susceptible factors based on recent advances that will further update the understanding of mechanisms involved in disease pathoetiology. Knowledge of these mechanisms will further assist in the creation of novel diagnostic and therapeutic options.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Akhil</LastName><ForeName>Akhil</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8953-2617</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, BMS-Block II, South Campus, Panjab University, Chandigarh, 160014, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bansal</LastName><ForeName>Rohit</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-2827-5685</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, BMS-Block II, South Campus, Panjab University, Chandigarh, 160014, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anupam</LastName><ForeName>Kumari</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-8134-9463</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Saint Louis University, St. Louis, MO, 63103, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tandon</LastName><ForeName>Ankit</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4668-5255</Identifier><AffiliationInfo><Affiliation>Department of Endocrinology, PGIMER, Chandigarh, 160012, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhatnagar</LastName><ForeName>Archana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7468-4423</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, BMS-Block II, South Campus, Panjab University, Chandigarh, 160014, India. bhatnagar.archana@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>191620089214</GrantID><Agency>University Grants Commission</Agency><Country/></Grant><Grant><GrantID>BT/INF/22/SP41295/2020</GrantID><Agency>Department of Biotechnology, Ministry of Science and Technology, India</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Rheumatol Int</MedlineTA><NlmUniqueID>8206885</NlmUniqueID><ISSNLinking>0172-8172</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="N">Epigenesis, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Environmental factors</Keyword><Keyword MajorTopicYN="N">Epigenetics</Keyword><Keyword MajorTopicYN="N">Etiology</Keyword><Keyword MajorTopicYN="N">Immunobiology</Keyword><Keyword MajorTopicYN="N">Lupus</Keyword><Keyword MajorTopicYN="N">Multifactorial interactions</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>25</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>24</Day><Hour>23</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37226016</ArticleId><ArticleId IdType="pmc">PMC10208557</ArticleId><ArticleId IdType="doi">10.1007/s00296-023-05346-x</ArticleId><ArticleId IdType="pii">10.1007/s00296-023-05346-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alaanzy MT, Alsaffar JM, Bari AA. Evaluate the correlation between antioxidant capacity and interferon &#x393; level with the disease activity of Sle patients in Iraqi Woman. Indian J Public Health Res Dev. 2020;11(1):1278&#x2013;1282. doi: 10.37506/v11/i1/2020/ijphrd/194018.</Citation><ArticleIdList><ArticleId IdType="doi">10.37506/v11/i1/2020/ijphrd/194018</ArticleId></ArticleIdList></Reference><Reference><Citation>Terahara N. Flavonoids in foods: a review. Nat Prod Commun. 2015;10(3):19345781501000334.</Citation><ArticleIdList><ArticleId IdType="pubmed">25924542</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok C, Lau C. Pathogenesis of systemic lupus erythematosus. J Clin Pathol. 2003;56(7):481&#x2013;490. doi: 10.1136/jcp.56.7.481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.56.7.481</ArticleId><ArticleId IdType="pmc">PMC1769989</ArticleId><ArticleId IdType="pubmed">12835292</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams DE, Shao W-H. Epigenetic alterations in immune cells of systemic Lupus erythematosus and therapeutic implications. Cells. 2022;11(3):506. doi: 10.3390/cells11030506.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11030506</ArticleId><ArticleId IdType="pmc">PMC8834103</ArticleId><ArticleId IdType="pubmed">35159315</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuyama T, Tsokos GC, Moulton VR. Aberrant T cell signaling and subsets in systemic lupus erythematosus. Front Immunol. 2018;9:1088. doi: 10.3389/fimmu.2018.01088.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01088</ArticleId><ArticleId IdType="pmc">PMC5967272</ArticleId><ArticleId IdType="pubmed">29868033</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma J, et al. Elevated interleukin-18 receptor accessory protein mediates enhancement in reactive oxygen species production in neutrophils of systemic lupus erythematosus patients. Cells. 2021;10(5):964. doi: 10.3390/cells10050964.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10050964</ArticleId><ArticleId IdType="pmc">PMC8143138</ArticleId><ArticleId IdType="pubmed">33919154</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertelli R, et al. Neutrophil extracellular traps in systemic lupus erythematosus stimulate IgG2 production from B lymphocytes. Front Med. 2021;8:635436. doi: 10.3389/fmed.2021.635436.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.635436</ArticleId><ArticleId IdType="pmc">PMC8072216</ArticleId><ArticleId IdType="pubmed">33912575</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Kaplan MJ. Neutrophil dysregulation in the pathogenesis of systemic lupus erythematosus. Rheum Dis Clin. 2021;47(3):317&#x2013;333. doi: 10.1016/j.rdc.2021.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rdc.2021.04.002</ArticleId><ArticleId IdType="pubmed">34215366</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan L, et al. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr. 2020;16(1):19&#x2013;30. doi: 10.1007/s12519-019-00229-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-019-00229-3</ArticleId><ArticleId IdType="pmc">PMC7040062</ArticleId><ArticleId IdType="pubmed">30796732</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasser N, Kurban M, Abbas O. Plasmacytoid dendritic cells and type I interferons in flares of systemic lupus erythematosus triggered by COVID-19. Rheumatol Int. 2021;41(5):1019&#x2013;1020. doi: 10.1007/s00296-021-04825-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-021-04825-3</ArticleId><ArticleId IdType="pmc">PMC7933913</ArticleId><ArticleId IdType="pubmed">33666725</ArticleId></ArticleIdList></Reference><Reference><Citation>Fillatreau S, Manfroi B, D&#xf6;rner T. Toll-like receptor signalling in B cells during systemic lupus erythematosus. Nat Rev Rheumatol. 2021;17(2):98&#x2013;108. doi: 10.1038/s41584-020-00544-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-020-00544-4</ArticleId><ArticleId IdType="pmc">PMC7747191</ArticleId><ArticleId IdType="pubmed">33339987</ArticleId></ArticleIdList></Reference><Reference><Citation>Brilland B, Scherlinger M, Khoryati L, Goret J, Duffau P, Lazaro E, Charrier M, Guillotin V, Richez C, Blanco P. Platelets and IgE: shaping the innate immune response in systemic lupus erythematosus. Clin Rev Allerg Immunol. 2019;58:1&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">31254159</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques CP, et al. Expression of Toll-like receptors 2 and 4 in the saliva of patients with systemic lupus erythematosus and chronic periodontitis. Clin Rheumatol. 2021;40(7):2727&#x2013;2734. doi: 10.1007/s10067-020-05560-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05560-z</ArticleId><ArticleId IdType="pubmed">33570702</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Zhang X, Cao X. Dendritic cells in systemic lupus erythematosus: from pathogenesis to therapeutic applications. J Autoimmun. 2022;132:102856. doi: 10.1016/j.jaut.2022.102856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2022.102856</ArticleId><ArticleId IdType="pubmed">35773101</ArticleId></ArticleIdList></Reference><Reference><Citation>Charrier M, et al. Systemic Lupus Erythematosus. Amsterdam: Elsevier; 2021. The role of dendritic cells in systemic lupus erythematosus; pp. 143&#x2013;150.</Citation></Reference><Reference><Citation>Sim TM, et al. Type I interferons in systemic lupus erythematosus: a journey from bench to bedside. Int J Mol Sci. 2022;23(5):2505. doi: 10.3390/ijms23052505.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23052505</ArticleId><ArticleId IdType="pmc">PMC8910773</ArticleId><ArticleId IdType="pubmed">35269647</ArticleId></ArticleIdList></Reference><Reference><Citation>Brilland B, et al. Platelets and IgE: shaping the innate immune response in systemic lupus erythematosus. Clin Rev Allergy Immunol. 2020;58(2):194&#x2013;212. doi: 10.1007/s12016-019-08744-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-019-08744-x</ArticleId><ArticleId IdType="pubmed">31254159</ArticleId></ArticleIdList></Reference><Reference><Citation>Palomares O, et al. Regulatory T cells and immunoglobulin E: a new therapeutic link for autoimmunity? Allergy. 2022;77:3293&#x2013;3308. doi: 10.1111/all.15449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15449</ArticleId><ArticleId IdType="pubmed">35852798</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, et al. Interferon-&#x3b1; activates interleukin-1 receptor-associated kinase 1 to induce regulatory T-cell apoptosis in patients with systemic lupus erythematosus. J Dermatol. 2021;48(8):1172&#x2013;1185. doi: 10.1111/1346-8138.15899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1346-8138.15899</ArticleId><ArticleId IdType="pubmed">33882150</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherlinger M, et al. Selectins impair regulatory T cell function and contribute to systemic lupus erythematosus pathogenesis. Sci Transl Med. 2021;13(600):eabi4994. doi: 10.1126/scitranslmed.abi4994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abi4994</ArticleId><ArticleId IdType="pubmed">34193612</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurata I, et al. Impaired function of PD-1+ follicular regulatory T cells in systemic lupus erythematosus. Clin Exp Immunol. 2021;206(1):28&#x2013;35. doi: 10.1111/cei.13643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13643</ArticleId><ArticleId IdType="pmc">PMC8446397</ArticleId><ArticleId IdType="pubmed">34240405</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima G, et al. Exhausted T cells in systemic lupus erythematosus patients in long-standing remission. Clin Exp Immunol. 2021;204(3):285&#x2013;295. doi: 10.1111/cei.13577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13577</ArticleId><ArticleId IdType="pmc">PMC8119791</ArticleId><ArticleId IdType="pubmed">33475152</ArticleId></ArticleIdList></Reference><Reference><Citation>Buang N, et al. Type I interferons affect the metabolic fitness of CD8+ T cells from patients with systemic lupus erythematosus. Nat Commun. 2021;12(1):1&#x2013;15. doi: 10.1038/s41467-021-22312-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22312-y</ArticleId><ArticleId IdType="pmc">PMC8012390</ArticleId><ArticleId IdType="pubmed">33790300</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, et al. Systemic lupus erythematosus favors the generation of IL-17 producing double negative T cells. Nat Commun. 2020;11(1):1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7275084</ArticleId><ArticleId IdType="pubmed">32503973</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdirama D, et al. Nuclear antigen&#x2013;reactive CD4+ T cells expand in active systemic lupus erythematosus, produce effector cytokines, and invade the kidneys. Kidney Int. 2021;99(1):238&#x2013;246. doi: 10.1016/j.kint.2020.05.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2020.05.051</ArticleId><ArticleId IdType="pubmed">32592813</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao H-J, et al. Increased HIF-1&#x3b1; expression in T cells and associated with enhanced Th17 pathway in systemic lupus erythematosus. J Formos Med Assoc. 2022;121:2446&#x2013;2456. doi: 10.1016/j.jfma.2022.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2022.05.003</ArticleId><ArticleId IdType="pubmed">35599104</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayamada S, Tanaka Y. Clinical relevance of T follicular helper cells in systemic lupus erythematosus. Expert Rev Clin Immunol. 2021;17(10):1143&#x2013;1150. doi: 10.1080/1744666X.2021.1976146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2021.1976146</ArticleId><ArticleId IdType="pubmed">34469695</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M, et al. AIM2 deficiency in B cells ameliorates systemic lupus erythematosus by regulating Blimp-1&#x2013;Bcl-6 axis-mediated B-cell differentiation. Signal Transduct Target Ther. 2021;6(1):1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440614</ArticleId><ArticleId IdType="pubmed">34521812</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P-M, Tsokos GC. T cell abnormalities in the pathogenesis of systemic lupus erythematosus: an update. Curr Rheumatol Rep. 2021;23(2):1&#x2013;9. doi: 10.1007/s11926-020-00978-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-020-00978-5</ArticleId><ArticleId IdType="pmc">PMC8601587</ArticleId><ArticleId IdType="pubmed">33512577</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang H-C, Tan T-H. MAP4K family kinases and DUSP family phosphatases in T-cell signaling and systemic lupus erythematosus. Cells. 2019;8(11):1433. doi: 10.3390/cells8111433.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8111433</ArticleId><ArticleId IdType="pmc">PMC6912701</ArticleId><ArticleId IdType="pubmed">31766293</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan W, et al. The regulatory subunit PPP2R2A of PP2A enhances Th1 and Th17 differentiation through activation of the GEF-H1/RhoA/ROCK signaling pathway. J Immunol. 2021;206(8):1719&#x2013;1728. doi: 10.4049/jimmunol.2001266.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2001266</ArticleId><ArticleId IdType="pmc">PMC8026731</ArticleId><ArticleId IdType="pubmed">33762326</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato H, Perl A. Double-edged sword: interleukin-2 promotes T regulatory cell differentiation but also expands interleukin-13-and interferon-&#x3b3;-producing CD8+ T Cells via STAT6-GATA-3 axis in systemic lupus erythematosus. Front Immunol. 2021;12:635531. doi: 10.3389/fimmu.2021.635531.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.635531</ArticleId><ArticleId IdType="pmc">PMC7982885</ArticleId><ArticleId IdType="pubmed">33763079</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong X, et al. Type I interferon&#x2013;activated STAT4 regulation of follicular helper T cell&#x2013;dependent cytokine and immunoglobulin production in Lupus. Arthritis Rheumatol. 2021;73(3):478&#x2013;489. doi: 10.1002/art.41532.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41532</ArticleId><ArticleId IdType="pmc">PMC7914134</ArticleId><ArticleId IdType="pubmed">33512094</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai X, et al. mTOR participates in the formation, maintenance, and function of memory CD8+ T cells regulated by glycometabolism. Biochem Pharmacol. 2022;204:115197. doi: 10.1016/j.bcp.2022.115197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2022.115197</ArticleId><ArticleId IdType="pubmed">35926651</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap DY, Chan TM. B cell abnormalities in systemic lupus erythematosus and lupus nephritis&#x2014;role in pathogenesis and effect of immunosuppressive treatments. Int J Mol Sci. 2019;20(24):6231. doi: 10.3390/ijms20246231.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20246231</ArticleId><ArticleId IdType="pmc">PMC6940927</ArticleId><ArticleId IdType="pubmed">31835612</ArticleId></ArticleIdList></Reference><Reference><Citation>Akita K, et al. Interferon &#x3b1; enhances B cell activation associated with FOXM1 induction: potential novel therapeutic strategy for targeting the plasmablasts of systemic lupus erythematosus. Front Immunol. 2020;11:498703. doi: 10.3389/fimmu.2020.498703.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.498703</ArticleId><ArticleId IdType="pmc">PMC7902015</ArticleId><ArticleId IdType="pubmed">33633721</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xe1;squez A, et al. Altered recruitment of Lyn, Syk and ZAP-70 into lipid rafts of activated B cells in systemic lupus erythematosus. Cell Signal. 2019;58:9&#x2013;19. doi: 10.1016/j.cellsig.2019.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2019.03.003</ArticleId><ArticleId IdType="pubmed">30840855</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, et al. Leptin accelerates B cell dysfunctions via activating JAK/STAT3/5 and ERK1/2 pathways in patients with systemic lupus erythematosus. Clin Exp Rheumatol. 2022;40(11):2125&#x2013;2132.</Citation><ArticleIdList><ArticleId IdType="pubmed">35084324</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen W-Y, et al. Up-regulation of proBDNF/p75NTR signaling in antibody-secreting cells drives systemic lupus erythematosus. Sci Adv. 2022;8(3):eabj2797. doi: 10.1126/sciadv.abj2797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abj2797</ArticleId><ArticleId IdType="pmc">PMC8769540</ArticleId><ArticleId IdType="pubmed">35044824</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon Q et al (2021) A cytokine network profile delineates a common Th1/Be1 pro-inflammatory group of patients in four systemic autoimmune diseases. Arthritis Rheumatol 73. 10.1002/art.41697</Citation><ArticleIdList><ArticleId IdType="pubmed">33605069</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon Q, et al. A pathogenic cytokine network is associated with pro-inflammatory B cells in systemic lupus erythematosus patients. SSRN J. 2019 doi: 10.2139/ssrn.3420376.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3420376</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka A, et al. Serum high-mobility group box 1 is correlated with interferon-&#x3b1; and may predict disease activity in patients with systemic lupus erythematosus. Lupus. 2019;28(9):1120&#x2013;1127. doi: 10.1177/0961203319862865.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203319862865</ArticleId><ArticleId IdType="pubmed">31299881</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J, et al. Cytokine clusters as potential diagnostic markers of disease activity and renal involvement in systemic lupus erythematosus. J Int Med Res. 2020;48(6):0300060520926882. doi: 10.1177/0300060520926882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300060520926882</ArticleId><ArticleId IdType="pmc">PMC7271280</ArticleId><ArticleId IdType="pubmed">32489126</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, et al. Interleukin-25 is upregulated in patients with systemic lupus erythematosus and ameliorates murine lupus by inhibiting inflammatory cytokine production. Int Immunopharmacol. 2019;74:105680. doi: 10.1016/j.intimp.2019.105680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2019.105680</ArticleId><ArticleId IdType="pubmed">31200339</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Z, et al. The plasma interleukin (IL)-35 level and frequency of circulating IL-35+ regulatory B cells are decreased in a cohort of Chinese patients with new-onset systemic lupus erythematosus. Sci Rep. 2019;9(1):1&#x2013;12. doi: 10.1038/s41598-019-49748-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-49748-z</ArticleId><ArticleId IdType="pmc">PMC6744462</ArticleId><ArticleId IdType="pubmed">31519970</ArticleId></ArticleIdList></Reference><Reference><Citation>Elshal A, et al. Serum interleukin-18 as a novel biomarker for disease activity of systemic lupus erythematosus patients. J Egypt Soc Parasitol. 2019;49(1):145&#x2013;152. doi: 10.21608/jesp.2019.68297.</Citation><ArticleIdList><ArticleId IdType="doi">10.21608/jesp.2019.68297</ArticleId></ArticleIdList></Reference><Reference><Citation>Shater H, et al. The potential use of serum interleukin-21 as biomarker for lupus nephritis activity compared to cytokines of the tumor necrosis factor (TNF) family. Lupus. 2022;31(1):55&#x2013;64. doi: 10.1177/09612033211063794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09612033211063794</ArticleId><ArticleId IdType="pubmed">34978958</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, et al. Potential role of interleukin-33 in systemic lupus erythematosus by regulating toll like receptor 4. Eur J Inflamm. 2022;20:1721727X221094455. doi: 10.1177/1721727X221094455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1721727X221094455</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding X, et al. Gene-based association analysis identified a novel gene associated with systemic lupus erythematosus. Ann Hum Genet. 2021;85(6):213&#x2013;220. doi: 10.1111/ahg.12439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ahg.12439</ArticleId><ArticleId IdType="pubmed">34145571</ArticleId></ArticleIdList></Reference><Reference><Citation>Putra Gofur NR, Putri Gofur AR, Soesilaningtyas RPGR, Kahdina M. Systemic lupus erythematsous: a review article. Int J Surg Case Rep Images. 2021;2(1):1.</Citation></Reference><Reference><Citation>Lever E, Alves MR, Isenberg DA. Towards precision medicine in systemic lupus erythematosus. Pharmacogen Personal Med. 2020;13:39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7007776</ArticleId><ArticleId IdType="pubmed">32099443</ArticleId></ArticleIdList></Reference><Reference><Citation>Dostanko N, et al. ab0010 association of some non-hla gene polymorphisms with susceptibility to systemic lupus erythematosus in women in belarusian population. London: BMJ Publishing Group Ltd.; 2022. pp. 1140&#x2013;1141.</Citation></Reference><Reference><Citation>Gharbia OM, et al. Toll-like receptor 5 and Toll-like receptor 9 single nucleotide polymorphisms and risk of systemic lupus erythematosus and nephritis in Egyptian patients. Egypt Rheumatol Rehabilit. 2021;48(1):1&#x2013;10.</Citation></Reference><Reference><Citation>Dias LNDS, et al. DNMT3B (rs2424913) polymorphism is associated with systemic lupus erythematosus alone and with co-existing periodontitis in a Brazilian population. J Appl Oral Sci. 2022 doi: 10.1590/1678-7757-2021-0567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1678-7757-2021-0567</ArticleId><ArticleId IdType="pmc">PMC9064189</ArticleId><ArticleId IdType="pubmed">35507987</ArticleId></ArticleIdList></Reference><Reference><Citation>Dan Y-L, et al. Association of PER2 gene single nucleotide polymorphisms with genetic susceptibility to systemic lupus erythematosus. Lupus. 2021;30(5):734&#x2013;740. doi: 10.1177/0961203321989794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203321989794</ArticleId><ArticleId IdType="pubmed">33497301</ArticleId></ArticleIdList></Reference><Reference><Citation>Umare V, et al. Cytokine genes multi-locus analysis reveals synergistic influence on genetic susceptibility in Indian SLE&#x2013;A multifactor-dimensionality reduction approach. Cytokine. 2020;135:155240. doi: 10.1016/j.cyto.2020.155240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2020.155240</ArticleId><ArticleId IdType="pubmed">32795905</ArticleId></ArticleIdList></Reference><Reference><Citation>Padhi S, et al. Interleukin 17A rs2275913 polymorphism is associated with susceptibility to systemic lupus erythematosus: a meta and trial sequential analysis. Lupus. 2022;31(6):674&#x2013;683. doi: 10.1177/09612033221090172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09612033221090172</ArticleId><ArticleId IdType="pubmed">35353646</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekinci RMK, et al. Monogenic lupus due to DNASE1L3 deficiency in a pediatric patient with urticarial rash, hypocomplementemia, pulmonary hemorrhage, and immune-complex glomerulonephritis. Eur J Med Genet. 2021;64(9):104262. doi: 10.1016/j.ejmg.2021.104262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmg.2021.104262</ArticleId><ArticleId IdType="pubmed">34161863</ArticleId></ArticleIdList></Reference><Reference><Citation>Liphaus BL, et al. LRBA deficiency: a new genetic cause of monogenic lupus. Ann Rheum Dis. 2020;79(3):427&#x2013;428. doi: 10.1136/annrheumdis-2019-216410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2019-216410</ArticleId><ArticleId IdType="pubmed">31852671</ArticleId></ArticleIdList></Reference><Reference><Citation>Pakzad B, et al. C1QTNF4 gene p His198Gln mutation is correlated with early-onset systemic lupus erythematosus in Iranian patients. Int J Rheum Dis. 2020;23(11):1594&#x2013;1598. doi: 10.1111/1756-185X.13981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.13981</ArticleId><ArticleId IdType="pubmed">33009720</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedrich CM. Systemic lupus erythematosus. Amsterdam: Elsevier; 2021. Epigenetics; pp. 277&#x2013;292.</Citation></Reference><Reference><Citation>Zhang Y, et al. Impaired DNA methylation and its mechanisms in CD4+ T cells of systemic lupus erythematosus. J Autoimmun. 2013;41:92&#x2013;99. doi: 10.1016/j.jaut.2013.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2013.01.005</ArticleId><ArticleId IdType="pubmed">23340289</ArticleId></ArticleIdList></Reference><Reference><Citation>He Z, et al. Comprehensive analysis of epigenetic modifications and immune-cell infiltration in tissues from patients with systemic lupus erythematosus. Epigenomics. 2022;14(2):81&#x2013;100. doi: 10.2217/epi-2021-0318.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/epi-2021-0318</ArticleId><ArticleId IdType="pubmed">34913398</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsou PS, et al. EZH2 modulates the DNA methylome and controls T cell adhesion through junctional adhesion molecule A in lupus patients. Arthritis Rheumatol. 2018;70(1):98&#x2013;108. doi: 10.1002/art.40338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40338</ArticleId><ArticleId IdType="pmc">PMC5745285</ArticleId><ArticleId IdType="pubmed">28973837</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X, Tsou P-S, Sawalha AH. Increased expression of EZH2 is mediated by higher glycolysis and mTORC1 activation in lupus CD4+ T cells. Immunometabolism. 2020 doi: 10.20900/immunometab20200013.</Citation><ArticleIdList><ArticleId IdType="doi">10.20900/immunometab20200013</ArticleId><ArticleId IdType="pmc">PMC7213603</ArticleId><ArticleId IdType="pubmed">32395334</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M, et al. Downregulation of BDH2 modulates iron homeostasis and promotes DNA demethylation in CD4+ T cells of systemic lupus erythematosus. Clin Immunol. 2018;187:113&#x2013;121. doi: 10.1016/j.clim.2017.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2017.11.002</ArticleId><ArticleId IdType="pubmed">29113828</ArticleId></ArticleIdList></Reference><Reference><Citation>Keshavarz-Fathi M, et al. DNA methylation of CD70 promoter in juvenile systemic lupus erythematosus. Fetal Pediatr Pathol. 2022;41(1):58&#x2013;67. doi: 10.1080/15513815.2020.1764681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15513815.2020.1764681</ArticleId><ArticleId IdType="pubmed">32427516</ArticleId></ArticleIdList></Reference><Reference><Citation>Vordenb&#xe4;umen S, et al. Associations of site-specific CD4+-T-cell hypomethylation within CD40-ligand promotor and enhancer regions with disease activity of women with systemic lupus erythematosus. Lupus. 2021;30(1):45&#x2013;51. doi: 10.1177/0961203320965690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203320965690</ArticleId><ArticleId IdType="pubmed">33081589</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo G, et al. Disease activity-associated alteration of mRNA m5 C methylation in CD4+ T cells of systemic lupus erythematosus. Front Cell Dev Biol. 2020;8:430. doi: 10.3389/fcell.2020.00430.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.00430</ArticleId><ArticleId IdType="pmc">PMC7291606</ArticleId><ArticleId IdType="pubmed">32582707</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanaei S, et al. The status of FOXP3 gene methylation in pediatric systemic lupus erythematosus. Allergol Immunopathol. 2020;48(4):332&#x2013;338. doi: 10.1016/j.aller.2020.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aller.2020.03.014</ArticleId><ArticleId IdType="pubmed">32475613</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong H, et al. Mesenchymal stem cells activate the MEK/ERK signaling pathway and enhance DNA methylation via DNMT1 in PBMC from systemic lupus erythematosus. BioMed Res Int. 2020;2020:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7685810</ArticleId><ArticleId IdType="pubmed">33282947</ArticleId></ArticleIdList></Reference><Reference><Citation>NosratZehi S, et al. Promoter methylation and expression status of cytotoxic T-lymphocyte-associated antigen-4 gene in patients with lupus. J Epigenetics. 2020;2(1):33&#x2013;39.</Citation></Reference><Reference><Citation>Sawalha AH, et al. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients. Clin Immunol. 2020;215:108410. doi: 10.1016/j.clim.2020.108410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108410</ArticleId><ArticleId IdType="pmc">PMC7139239</ArticleId><ArticleId IdType="pubmed">32276140</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, et al. LncRNA GAS5 suppresses CD4+ T cell activation by upregulating E4BP4 via inhibiting miR-92a-3p in systemic lupus erythematosus. Immunol Lett. 2020;2021:41&#x2013;47. doi: 10.1016/j.imlet.2020.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2020.08.001</ArticleId><ArticleId IdType="pubmed">32781006</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo G, et al. Epitranscriptomic N4-acetylcytidine profiling in CD4+ T cells of systemic lupus erythematosus. Front Cell Dev Biol. 2020;8:842. doi: 10.3389/fcell.2020.00842.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.00842</ArticleId><ArticleId IdType="pmc">PMC7483482</ArticleId><ArticleId IdType="pubmed">32984334</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao B, et al. Regulation of Toll-like receptor-mediated inflammatory response by microRNA-152-3p-mediated demethylation of MyD88 in systemic lupus erythematosus. Inflamm Res. 2021;70(3):285&#x2013;296. doi: 10.1007/s00011-020-01433-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-020-01433-y</ArticleId><ArticleId IdType="pubmed">33507312</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S, Zhang J, Luan P, Ma Z, Dang J, Zhu H, Huo Z. miR-183&#x2013;5p is a potential molecular marker of systemic lupus erythematosus. J Immunol Res. 2021;2021:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8124875</ArticleId><ArticleId IdType="pubmed">34036107</ArticleId></ArticleIdList></Reference><Reference><Citation>Pyfrom S, et al. The dynamic epigenetic regulation of the inactive X chromosome in healthy human B cells is dysregulated in lupus patients. Proc Natl Acad Sci. 2021 doi: 10.1073/pnas.2024624118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024624118</ArticleId><ArticleId IdType="pmc">PMC8214693</ArticleId><ArticleId IdType="pubmed">34103397</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhen Y, et al. Ezh2-mediated epigenetic modification is required for allogeneic T cell-induced lupus disease. Arthritis Res Ther. 2020;22:1&#x2013;10. doi: 10.1186/s13075-020-02225-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-020-02225-9</ArticleId><ArticleId IdType="pmc">PMC7275547</ArticleId><ArticleId IdType="pubmed">32503684</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi X, et al. Downregulated miR-29a promotes B cell overactivation by upregulating Crk-like protein in systemic lupus erythematosus. Mol Med Rep. 2020;22(2):841&#x2013;849. doi: 10.3892/mmr.2020.11166.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2020.11166</ArticleId><ArticleId IdType="pmc">PMC7339478</ArticleId><ArticleId IdType="pubmed">32467986</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, et al. Deficiency of p53 causes the inadequate expression of miR-1246 in B cells of systemic lupus erythematosus. J Immunol. 2022;209(8):1492&#x2013;1498. doi: 10.4049/jimmunol.2200307.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2200307</ArticleId><ArticleId IdType="pmc">PMC9527209</ArticleId><ArticleId IdType="pubmed">36165173</ArticleId></ArticleIdList></Reference><Reference><Citation>Scharer CD, et al. Epigenetic programming underpins B cell dysfunction in human SLE. Nat Immunol. 2019;20(8):1071&#x2013;1082. doi: 10.1038/s41590-019-0419-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-019-0419-9</ArticleId><ArticleId IdType="pmc">PMC6642679</ArticleId><ArticleId IdType="pubmed">31263277</ArticleId></ArticleIdList></Reference><Reference><Citation>Fali T, et al. DNA methylation modulates HRES1/p28 expression in B cells from patients with Lupus. Autoimmunity. 2014;47(4):265&#x2013;271. doi: 10.3109/08916934.2013.826207.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08916934.2013.826207</ArticleId><ArticleId IdType="pmc">PMC4034120</ArticleId><ArticleId IdType="pubmed">24117194</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan H, et al. Gender differences of B cell signature related to estrogen-induced IFI44L/BAFF in systemic lupus erythematosus. Immunol Lett. 2017;181:71&#x2013;78. doi: 10.1016/j.imlet.2016.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2016.12.002</ArticleId><ArticleId IdType="pubmed">27923569</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam P, Sharma A, Bhatnagar A. Global histone modification analysis reveals hypoacetylated H3 and H4 histones in B Cells from systemic lupus erythematosus patients. Immunol Lett. 2021;240:41&#x2013;45. doi: 10.1016/j.imlet.2021.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2021.09.007</ArticleId><ArticleId IdType="pubmed">34614442</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo M, et al. The regulatory effect of ERK1 pathway in the DNA hypomethylation of MRL/lpr Mice. Int J Immunol. 2021;9(3):41. doi: 10.11648/j.iji.20210903.11.</Citation><ArticleIdList><ArticleId IdType="doi">10.11648/j.iji.20210903.11</ArticleId></ArticleIdList></Reference><Reference><Citation>Ao T, Kikuta J, Ishii M. The effects of vitamin D on immune system and inflammatory diseases. Biomolecules. 2021;11(11):1624. doi: 10.3390/biom11111624.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11111624</ArticleId><ArticleId IdType="pmc">PMC8615708</ArticleId><ArticleId IdType="pubmed">34827621</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi K, et al. Real-world data on vitamin D supplementation and its impacts in systemic lupus erythematosus: cross-sectional analysis of a lupus registry of nationwide institutions (LUNA) PLoS&#xa0;One. 2022;17(6):e0270569. doi: 10.1371/journal.pone.0270569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0270569</ArticleId><ArticleId IdType="pmc">PMC9242469</ArticleId><ArticleId IdType="pubmed">35767524</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrlich R. Silica&#x2014;a multisystem hazard. Int J Epidemiol. 2021;50(4):1226&#x2013;1228. doi: 10.1093/ije/dyab020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyab020</ArticleId><ArticleId IdType="pubmed">33570131</ArticleId></ArticleIdList></Reference><Reference><Citation>Boudigaard SH, et al. Occupational exposure to respirable crystalline silica and risk of autoimmune rheumatic diseases: a nationwide cohort study. Int J Epidemiol. 2021;50(4):1213&#x2013;1226. doi: 10.1093/ije/dyaa287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyaa287</ArticleId><ArticleId IdType="pmc">PMC8407872</ArticleId><ArticleId IdType="pubmed">33462590</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown J, et al. Silica accelerated systemic autoimmune disease in lupus-prone New Zealand mixed mice. Clin Exp Immunol. 2003;131(3):415&#x2013;421. doi: 10.1046/j.1365-2249.2003.02094.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2249.2003.02094.x</ArticleId><ArticleId IdType="pmc">PMC1808650</ArticleId><ArticleId IdType="pubmed">12605693</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilcrease GW, et al. Is air pollution affecting the disease activity in patients with systemic lupus erythematosus? State of the art and a systematic literature review. Eur J Rheumatol. 2020;7(1):31. doi: 10.5152/eurjrheum.2019.19141.</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/eurjrheum.2019.19141</ArticleId><ArticleId IdType="pmc">PMC7001995</ArticleId><ArticleId IdType="pubmed">32023206</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilburn KH, Warshaw RH. Prevalence of symptoms of systemic lupus erythematosus (SLE) and of fluorescent antinuclear antibodies associated with chronic exposure to trichloroethylene and other chemicals in well water. Environ Res. 1992;57(1):1&#x2013;9. doi: 10.1016/S0013-9351(05)80014-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0013-9351(05)80014-3</ArticleId><ArticleId IdType="pubmed">1740091</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper GS, et al. Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents. Rheumatology. 2010;49(11):2172&#x2013;2180. doi: 10.1093/rheumatology/keq214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keq214</ArticleId><ArticleId IdType="pmc">PMC2954367</ArticleId><ArticleId IdType="pubmed">20675707</ArticleId></ArticleIdList></Reference><Reference><Citation>Perricone C, et al. Smoke and autoimmunity: the fire behind the disease. Autoimmun Rev. 2016;15(4):354&#x2013;374. doi: 10.1016/j.autrev.2016.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2016.01.001</ArticleId><ArticleId IdType="pubmed">26772647</ArticleId></ArticleIdList></Reference><Reference><Citation>Speyer CB, Costenbader KH. Cigarette smoking and the pathogenesis of systemic lupus erythematosus. Expert Rev Clin Immunol. 2018;14(6):481&#x2013;487. doi: 10.1080/1744666X.2018.1473035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2018.1473035</ArticleId><ArticleId IdType="pmc">PMC7069669</ArticleId><ArticleId IdType="pubmed">29724134</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain MS, Tripathi V. Smoking under hypoxic conditions: a potent environmental risk factor for inflammatory and autoimmune diseases. Mil Med Res. 2018;5(1):1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5877397</ArticleId><ArticleId IdType="pubmed">29598831</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, et al. The relationship of polluted air and drinking water sources with the prevalence of systemic lupus erythematosus: a provincial population-based study. Sci Rep. 2021;11(1):1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8452734</ArticleId><ArticleId IdType="pubmed">34545152</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, et al. Association between alcohol intake and the risk of systemic lupus erythematosus: a systematic review and meta-analysis. Lupus. 2021;30(5):725&#x2013;733. doi: 10.1177/0961203321991918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203321991918</ArticleId><ArticleId IdType="pubmed">33557684</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, et al. Major infections in newly diagnosed systemic lupus erythematosus: an inception cohort study. Lupus Sci Med. 2022;9(1):e000725. doi: 10.1136/lupus-2022-000725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2022-000725</ArticleId><ArticleId IdType="pmc">PMC9438011</ArticleId><ArticleId IdType="pubmed">36041813</ArticleId></ArticleIdList></Reference><Reference><Citation>James JA, et al. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum. 2001;44(5):1122&#x2013;1126. doi: 10.1002/1529-0131(200105)44:5&lt;1122::AID-ANR193&gt;3.0.CO;2-D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(200105)44:5&lt;1122::AID-ANR193&gt;3.0.CO;2-D</ArticleId><ArticleId IdType="pubmed">11352244</ArticleId></ArticleIdList></Reference><Reference><Citation>Poole BD, et al. Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity. 2006;39(1):63&#x2013;70. doi: 10.1080/08916930500484849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916930500484849</ArticleId><ArticleId IdType="pubmed">16455583</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand P, et al. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC. Elife. 2020;9:e58603. doi: 10.7554/eLife.58603.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.58603</ArticleId><ArticleId IdType="pmc">PMC7343387</ArticleId><ArticleId IdType="pubmed">32452762</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu X-L, et al. COVID-19 in patients with systemic lupus erythematosus: a systematic review. Lupus. 2022;31(6):684&#x2013;696. doi: 10.1177/09612033221093502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09612033221093502</ArticleId><ArticleId IdType="pmc">PMC8990101</ArticleId><ArticleId IdType="pubmed">35382637</ArticleId></ArticleIdList></Reference><Reference><Citation>Schioppo T, et al. Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patients. Rheumatology. 2022;61(5):1928&#x2013;1935. doi: 10.1093/rheumatology/keab611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keab611</ArticleId><ArticleId IdType="pmc">PMC8385869</ArticleId><ArticleId IdType="pubmed">34352079</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira GL. Probiotics-current knowledge and future prospects. Houston: InTech; 2018. Probiotic applications in autoimmune diseases; pp. 69&#x2013;89.</Citation></Reference><Reference><Citation>Luo XM, et al. Gut microbiota in human systemic lupus erythematosus and a mouse model of lupus. Appl Environ Microbiol. 2018;84(4):e02288&#x2013;e2317. doi: 10.1128/AEM.02288-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.02288-17</ArticleId><ArticleId IdType="pmc">PMC5795066</ArticleId><ArticleId IdType="pubmed">29196292</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman H, Koren O. The gut microbiota: a possible factor influencing systemic lupus erythematosus. Curr Opin Rheumatol. 2017;29(4):374&#x2013;377. doi: 10.1097/BOR.0000000000000395.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000395</ArticleId><ArticleId IdType="pubmed">28376066</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, et al. Dynamics of gut microbiota in autoimmune lupus. Appl Environ Microbiol. 2014;80(24):7551&#x2013;7560. doi: 10.1128/AEM.02676-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.02676-14</ArticleId><ArticleId IdType="pmc">PMC4249226</ArticleId><ArticleId IdType="pubmed">25261516</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelhamid L, Luo XM. Retinoic acid, leaky gut, and autoimmune diseases. Nutrients. 2018;10(8):1016. doi: 10.3390/nu10081016.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu10081016</ArticleId><ArticleId IdType="pmc">PMC6115935</ArticleId><ArticleId IdType="pubmed">30081517</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzouz D, et al. Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal. Ann Rheum Dis. 2019;78(7):947&#x2013;956. doi: 10.1136/annrheumdis-2018-214856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2018-214856</ArticleId><ArticleId IdType="pmc">PMC6585303</ArticleId><ArticleId IdType="pubmed">30782585</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogunrinde E, et al. A link between plasma microbial translocation, microbiome, and autoantibody development in first-degree relatives of systemic lupus erythematosus patients. Arthritis Rheumatol. 2019;71(11):1858&#x2013;1868. doi: 10.1002/art.40935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40935</ArticleId><ArticleId IdType="pmc">PMC6817371</ArticleId><ArticleId IdType="pubmed">31106972</ArticleId></ArticleIdList></Reference><Reference><Citation>Tursi SA, et al. Bacterial amyloid curli acts as a carrier for DNA to elicit an autoimmune response via TLR2 and TLR9. PLoS Pathog. 2017;13(4):e1006315. doi: 10.1371/journal.ppat.1006315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006315</ArticleId><ArticleId IdType="pmc">PMC5406031</ArticleId><ArticleId IdType="pubmed">28410407</ArticleId></ArticleIdList></Reference><Reference><Citation>Mardani F, et al. In vivo study: Th1&#x2013;Th17 reduction in pristane-induced systemic lupus erythematosus mice after treatment with tolerogenic Lactobacillus probiotics. J Cell Physiol. 2019;234(1):642&#x2013;649. doi: 10.1002/jcp.26819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.26819</ArticleId><ArticleId IdType="pubmed">30078223</ArticleId></ArticleIdList></Reference><Reference><Citation>dos Santos FDMM, et al. Excess weight and associated risk factors in patients with systemic lupus erythematosus. Rheumatol Int. 2013;33(3):681&#x2013;688. doi: 10.1007/s00296-012-2402-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-012-2402-8</ArticleId><ArticleId IdType="pubmed">22527136</ArticleId></ArticleIdList></Reference><Reference><Citation>Kono M, et al. The impact of obesity and a high-fat diet on clinical and immunological features in systemic lupus erythematosus. Nutrients. 2021;13(2):504. doi: 10.3390/nu13020504.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13020504</ArticleId><ArticleId IdType="pmc">PMC7913625</ArticleId><ArticleId IdType="pubmed">33557015</ArticleId></ArticleIdList></Reference><Reference><Citation>Kono M, et al. The impact of obesity and a high-fat diet on clinical and immunological features in systemic lupus erythematosus. Nutrients. 2021;13:504. doi: 10.3390/nu13020504.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13020504</ArticleId><ArticleId IdType="pmc">PMC7913625</ArticleId><ArticleId IdType="pubmed">33557015</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, et al. Spirulina lipids alleviate oxidative stress and inflammation in mice fed a high-fat and high-sucrose diet. Mar Drugs. 2020;18(3):148. doi: 10.3390/md18030148.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/md18030148</ArticleId><ArticleId IdType="pmc">PMC7143263</ArticleId><ArticleId IdType="pubmed">32143330</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Kaplan MJ. Cardiovascular disease in systemic lupus erythematosus: an update. Curr Opin Rheumatol. 2018;30(5):441&#x2013;448. doi: 10.1097/BOR.0000000000000528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000528</ArticleId><ArticleId IdType="pubmed">29870498</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang J-H, et al. Obesity increases the incidence of new-onset lupus nephritis and organ damage during follow-up in patients with systemic lupus erythematosus. Lupus. 2020;29(6):578&#x2013;586. doi: 10.1177/0961203320913616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203320913616</ArticleId><ArticleId IdType="pubmed">32208798</ArticleId></ArticleIdList></Reference><Reference><Citation>La Cava A. The influence of diet and obesity on gene expression in SLE. Genes. 2019;10(5):405. doi: 10.3390/genes10050405.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes10050405</ArticleId><ArticleId IdType="pmc">PMC6562976</ArticleId><ArticleId IdType="pubmed">31137916</ArticleId></ArticleIdList></Reference><Reference><Citation>Constantin MM, et al. Significance and impact of dietary factors on systemic lupus erythematosus pathogenesis. Exp Ther Med. 2019;17(2):1085&#x2013;1090.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6327661</ArticleId><ArticleId IdType="pubmed">30679978</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao ZX, et al. High salt diet accelerates the progression of murine lupus through dendritic cells via the p38 MAPK and STAT1 signaling pathways. Signal Transduct Target Ther. 2020;5(1):1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7145808</ArticleId><ArticleId IdType="pubmed">32296043</ArticleId></ArticleIdList></Reference><Reference><Citation>Correa-Rodr&#xed;guez M, et al. Dietary sodium, potassium, and sodium to potassium ratio in patients with systemic lupus erythematosus. Biol Res Nurs. 2022;24:10998004211065491. doi: 10.1177/10998004211065491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10998004211065491</ArticleId><ArticleId IdType="pubmed">34978207</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi A, et al. Dietary supplementation with eicosapentaenoic acid inhibits plasma cell differentiation and attenuates lupus autoimmunity. Front Immunol. 2021 doi: 10.3389/fimmu.2021.650856.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.650856</ArticleId><ArticleId IdType="pmc">PMC8240640</ArticleId><ArticleId IdType="pubmed">34211460</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam MA, et al. Immunomodulatory effects of diet and nutrients in systemic lupus erythematosus (SLE): a systematic review. Front Immunol. 2020;11:1477. doi: 10.3389/fimmu.2020.01477.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01477</ArticleId><ArticleId IdType="pmc">PMC7387408</ArticleId><ArticleId IdType="pubmed">32793202</ArticleId></ArticleIdList></Reference><Reference><Citation>Pocovi-Gerardino G, et al. Beneficial effect of Mediterranean diet on disease activity and cardiovascular risk in systemic lupus erythematosus patients: a cross-sectional study. Rheumatology. 2021;60(1):160&#x2013;169. doi: 10.1093/rheumatology/keaa210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa210</ArticleId><ArticleId IdType="pubmed">32594173</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>